← Scroll for more →
Financial Statements — SOPH
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q1 2025 | Q4 2024 | Q1 2024 | Q4 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 70.29 | -- | 80.23 | -- | 123.25 | -- | 161.31 | -- | 192.96 |
| Inventory | 6.35 | -- | 5.87 | -- | 6.48 | -- | 5.16 | -- | 5.73 |
| Total Current Assets | 99.08 | -- | 99.41 | -- | 148.05 | -- | 196.26 | -- | 282.86 |
| Total Non-current Assets | 63.95 | -- | 55.90 | -- | 58.11 | -- | 47.58 | -- | 37.32 |
| Total Assets | 163.03 | -- | 155.31 | -- | 206.16 | -- | 243.84 | -- | 320.17 |
| Total Current Liabilities | 50.53 | -- | 26.80 | -- | 35.62 | -- | 26.81 | -- | 28.60 |
| Total Non-current Liabilities | 65.36 | -- | 32.02 | -- | 19.09 | -- | 16.90 | -- | 16.17 |
| Total Liabilities | 115.89 | -- | 58.82 | -- | 54.71 | -- | 43.71 | -- | 44.77 |
| Retained Earnings | (519.28) | -- | (440.28) | -- | (377.78) | -- | (298.80) | -- | (211.35) |
| Total Stockholder Equity | 47.15 | 85.61 | 96.49 | 132.23 | 151.44 | 184.91 | 200.13 | 251.91 | 275.40 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Total Revenue | 18.32 | 15.81 | 15.05 | 11.67 |
| Cost of Revenue* | 6.05 | 5.03 | 5.01 | 4.05 |
| Gross Profit | 12.27 | 10.78 | 10.05 | 7.62 |
| Research & Development | 8.49 | 7.96 | 8.89 | 8.99 |
| Selling, General & Admin | 12.30 | 10.58 | 14.04 | 14.70 |
| Total Operating Expenses* | 30.76 | 25.78 | 30.09 | 31.70 |
| Operating Income | (18.49) | (15.00) | (20.05) | (24.08) |
| Interest Expense | 0.56 | 0.50 | -- | -- |
| Pretax Income | (21.65) | (15.03) | (21.32) | (24.69) |
| Tax Provision | 0.76 | 0.16 | 0.07 | (0.01) |
| Net Income | (22.41) | (15.19) | (21.40) | (24.68) |
| Basic EPS | (0.33) | (0.23) | (0.33) | (0.39) |
| Diluted EPS | (0.33) | (0.23) | (0.33) | (0.39) |
← Scroll for more columns →
* Derived from reported values